1. Home/
  2. Compounds/
  3. GSK-1904529A



SourcesNames Used
PharmacoGx GSK-1904529A

External IDs

Smiles: CCC1=CC(=C(C=C1N2CCC(CC2)N3CCN(CC3)S(=O)(=O)C)OC)NC4=NC=CC(=N4)C5=C(N=C6N5C=CC=C6)C7=CC(=C(C=C7)OC)C(=O)NC8=C(C=CC=C8F)F
Pubchem: 25124816

Annotated Targets


Cell lines tested with GSK-1904529A

932 cell lines have been tested with this compound, using data from 1 dataset(s).
RPMI-8866 haematopoietic and lymphoid tissue GDSC10001
BT-483 breast GDSC10001
VCaP prostate GDSC10001
NCI-H716 large intestine GDSC10001
MN-60 haematopoietic and lymphoid tissue GDSC10001
SW962 vulva GDSC10001
EB2 haematopoietic and lymphoid tissue GDSC10001
COLO-800 skin GDSC10001
MKN45 stomach GDSC10001
CAL-120 breast GDSC10001
Download CSV
Download Data as CSV

Top molecular features associated with response to GSK-1904529A

Feature TypeStandardized
Nominal ANOVA
mRNA EGR1 GDSC1000 AAC 0.22 3e-09
mRNA TNFRSF12A GDSC1000 AAC 0.24 4e-07
mRNA SERTAD1 GDSC1000 AAC 0.17 1e-06
mRNA IER5L GDSC1000 AAC 0.18 2e-06
mRNA CSRNP1 GDSC1000 AAC 0.16 2e-06
mRNA SPATA22 GDSC1000 AAC 0.17 3e-06
mRNA FOS GDSC1000 AAC 0.19 3e-06
mRNA VMP1 GDSC1000 AAC 0.17 7e-06
mRNA THOC1 GDSC1000 AAC -0.16 9e-06
mRNA XAGE2 GDSC1000 AAC 0.15 9e-06
Download CSV